Inhibitory Effect of Hypothalamic Stimulation on Growth Hormone (GH) Release Induced by GH-Releasing Factor in the Rat*
- 1 January 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 116 (1) , 382-388
- https://doi.org/10.1210/endo-116-1-382
Abstract
The topography of hypothalamic areas related to the suppression of GH [growth hormone] release induced by human pancreatic GH-releasing factor (hpGRF) was clarified. One week before the experiments, bipolar concentric stimulating electrodes were implanted in the organum vasculosum of the lamina terminalis (OVLT), the periventricular nucleus of the hypothalamus (Pe), the ventromedial nucleus of the hypothalamus (VMH), the lateral hypothalamic area (LHA), or the ventral premammillary nucleus (PMV). At the same time, the jugular vein was cannulated for blood sampling, and lesion of the anterior Pe was performed with a cathodal current. One and one half hours before the 1st blood sampling the rats were anesthetized with pentobarbital to prevent spontaneous GH bursts. One minute after the 1st blood sampling, 10 .mu.g hpGRF dissolved in 0.3 ml saline was injected i.v. through the cannula. The blood samples were collected at 10, 20, 30, and 60 min after the zero-time sample. The above mentioned hypothalamic nuclei were electrically stimulated for the first 10 min. Injection of hpGRF increased the plasma GH level from 44.2 .+-. 7.3 ng/ml (mean .+-. SE) to 981.4 .+-. 59.8 ng/ml in 10 min, and the plasma GH level gradually decreased to 50.8 .+-. 8.8 ng/ml by 60 min. The hpGRF-induced GH release was most effectively suppressed by the stimulation of the Pe. After the stimulation of the OVLT, the VMH, the LHA, or the PMV, the suppression of hpGRF-induced GH release was weaker than that of the Pe. This stimulation-induced suppression was fully or partly prevented in Pe-lesioned animals. Apparently the stimulation of the Pe, the OVLT, the VMH, the LHA, or the PMV exerts an inhibitory effect on GH release. For this inhibitory effect, the Pe was essential. The topography of immunoreactive SRIF [somatostatin] neuronal cell bodies and processes in the hypothalamus is discussed.This publication has 15 references indexed in Scilit:
- Acrolein: a fixative for immunocytochemical localization of peptides in the central nervous system.Journal of Histochemistry & Cytochemistry, 1983
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982
- Immunohistochemical studies of intrahypothalamic somatostatin-containing neurons in ratBrain Research, 1982
- Topography of median eminence somatostatinergic innervationBrain Research, 1981
- The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous systemNeuroscience, 1981
- Distribution of somatostatin in the rat brain: Telencephalon and diencephalonBrain Research, 1980
- Enhancement of Immunoreactive Somatostatin Release into Hypophysial Portal Blood by Electrical Stimulation of the Preoptic Area in the Rat*Endocrinology, 1979
- Immunocytochemical localization of somatostatin-containing neurons in the rat hypothalamusCell and tissue research, 1979
- Intrahypothalamic connections: An electron microscopic study in the ratExperimental Brain Research, 1979
- Effects of Brain Lesions and Hypothalamic Deafferentation on Somatostatin Distribution in the Rat BrainEndocrinology, 1977